SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Divis Laboratories
Divis Laboratories
BSE: 532488|NSE: DIVISLAB|ISIN: INE361B01024|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jul 30, 17:00
1491.20
20.9 (1.42%)
VOLUME 24,487
LIVE
NSE
Jul 30, 17:00
1491.55
19 (1.29%)
VOLUME 123,380
News on Divis Laboratories
Select Year: 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Buy Bharat Forge, Amara Raja, Divis Labs: Dharmesh Kant 

1.56 pm | 28 Jul 2014 |  Source: CNBC-TV18

Dharmesh Kant of India Nivesh Securities recommends buying Alembic Pharma with a target of Rs 360 and Divis Lab for a price target of Rs 1,550....

Buy HCL Tech, Divis Labs; sell Tata Motors DVR: Malkan 

1.55 pm | 28 Jul 2014 |  Source: CNBC-TV18

Vishal B Malkan of malkansview.com recommends seling Tata Motors (DVR) with a target of Rs 270 and advises buying India Cements with a target of Rs 11...

Bull's Eye: Buy HCL Tech, Divis Labs, Eveready, Amara Raja 

8.55 am | 28 Jul 2014 |  Source: CNBC-TV18

Vishal Malkan, malkansview.com advises buying HCL Technologies for a target price of Rs 1,625 and Divis Labs for a target price of Rs 1,525....

Buy Divis Labs, Zee Entertainment, Tata Motors: Sukhani 

2.49 pm | 24 Jul 2014 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com recommends buying Divis Laboratories, Zee Entertainment Enterprises and Tata Motors....

Sharekhan positive on pharma; prefers Aurobindo, Torrent

7.03 pm | 15 Jul 2014 |  Source: Moneycontrol.com

Sharekhan has come out with its report on pharma sector. The research firm remains positive on the pharmaceutical sector and maintain buy rating on Au...

Buy Divis Laboratories: Sudarshan Sukhani 

10.13 am | 14 Jul 2014 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one may buy Divis Laboratories....

Prefer Aurobindo, Cadila, Divis, Torrent Pharma: Sharekhan

1.29 pm | 10 Jul 2014 |  Source: Moneycontrol.com

Sharekhan has come out with its Q1FY2015 pharma earnings preview. According to the research firm, Aurobindo Pharma, Cadila Healthcare, Divis Laborator...

Buy Tech Mahindra, JSW Energy, Divis Labs: Vishal Malkan 

12.26 pm | 03 Jul 2014 |  Source: CNBC-TV18

Vishal Malkan of malkansview.com recommends buying Divis Labs for a target of Rs 1,575 and Tata Chemicals for a target price of Rs 375....

Bull's Eye: Buy Aurobindo, Titan, Tech Mahindra, Jai Corp 

9.07 am | 03 Jul 2014 |  Source: CNBC-TV18

Akshata Deshmukh, Trading Networth Capital advises buying Aurobindo Pharma for a target price of Rs 795 and DCB Bank for a target price of Rs 89....

Buy Divis Laboratories, ACC: Sudarshan Sukhani 

3.20 pm | 02 Jul 2014 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one may buy Divis Laboratories, ACC and ITC....

Here are some top buzzing stocks 

12.26 pm | 27 Jun 2014 |  Source: Moneycontrol.com

Here's a look at the top buzzing stocks....

Buy ABB, Divis Labs, ING Vysya Bank: AK Prabharkar 

11.59 am | 27 Jun 2014 |  Source: CNBC-TV18

AK Prabharkar, Independent Advisor is of the view that one may buy Prestige Estates Projects for a target of Rs 254 and ING Vysya Bank for a target of...

Bull's Eye: Buy Reliance Cap, Tata Global, Prestige Estates 

8.50 am | 27 Jun 2014 |  Source: CNBC-TV18

Dharmesh Kant of India Nivesh Securities advises buying Exide Industries for a target price of Rs 150 and Deepak Fertilizers for a target price of Rs ...

Super Six stocks you can bet on June 27

8.25 am | 27 Jun 2014 |  Source: CNBC-TV18

Vishal Kshatriya of Edelweiss advises buying UPL with a target of Rs 350 and Biocon with a target of Rs 550....

Divis Laboratories: Outcome of board meeting

8.00 pm | 23 Jun 2014 |  Source: Moneycontrol.com

Divis Laboratories has informed that the Board of Directors of the Company at its meeting held on June 23, 2014, has appointed Sri. K. V. K. Seshavata...

Divis Labs' inspection of unit-I by US-FDA

11.46 am | 21 Jun 2014 |  Source: Moneycontrol.com

Divis Laboratories has had a successful inspection by the US-FDA from June 16 to 20, 2014, without any observations, for its Unit-I at vill. Lingojigu...

Buy Divis Labs; target of Rs 1425: ICICIdirect

12.27 pm | 28 May 2014 |  Source: Moneycontrol.com

ICICIdirect.com is bullish on Divis Laboratories and has recommended buy rating on the stock with a target of Rs 1425 in its May 27, 2014 research rep...

Buy Divis Laboratories; target of Rs 1419: Emkay

11.05 am | 28 May 2014 |  Source: Moneycontrol.com

Brokerage house Emkay Global Financial Services is bullish on Divis Laboratories and has recommended buy rating on the stock with a target price of Rs...

Divis Labs consolidated Mar '14 sales at Rs 750.21 crore

2.05 pm | 27 May 2014 |  Source: Moneycontrol.com

Divis Laboratories has reported a sales turnover of Rs 750.21 crore and a net profit of Rs 196.43 crore for the quarter ended Mar '14...

Buy Divis Laboratories; target of Rs 1500: Sharekhan

11.57 am | 27 May 2014 |  Source: Moneycontrol.com

Sharekhan is bullish on Divis Laboratories and has recommended buy rating on the stock with a target of Rs 1500 in its May 26, 2014 research report....

1 2 3
Quick Links for Divis Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.